Blood Clotting
Segment of Blood Clotting Factor Set to Drive Global Protein Therapeutics Market
According to our latest research study, “Global Protein Therapeutics Market Analysis”, the growth experienced in the segment under blood clotting factors will boost the overall growth of global protein therapeutics market in the coming years. The growth in the blood clotting factor market is based on the rising population with increase in the number of hemophilia patients, new innovations in drug delivery, better therapies with less side effects, and increasing provisions of health insurance. Besides, the increasing regulatory support around the world towards the segment along with increasing generic competition will help the blood clotting market to grow at a CAGR of around 17% during 2012-2014.
Besides, our report also provides a thorough research and prudent analysis of global protein therapeutics market. The systematic and thorough research studies the global protein therapeutics market that will provide an insight into its various segments including Monoclonal Antibodies, Erythropoietins, Insulin, Interferon, Human Growth Hormone, Granulocyte Colony Stimulating Factor, and Follicle Stimulating Hormone. The comprehensive analysis of the market states blood clotting factors to be one of the highest shareholders at present.
We have identified some critical factors acting as a catalyst for the industry’s current and future growth outlook. The report reveals that increase in the health insurance industry will drive renewed interest of the investors in the therapeutics market at the global level. Moreover, higher incidence of lifestyle and chronic diseases, such as cancer, arthritis, etc. will pave the way for the growth of the market in coming years. In terms of technology, the focus of the research community is shifting towards synthetic biology and the development of drug-like therapies and multi-functional therapies.
“Global Protein Therapeutics Market Analysis” provides thorough research and rational analysis along with reliable statistics on the global protein therapeutics market. The report also provides extensive information on the traditional markets as well as on the emerging technologies. Analysis and statistics regarding market size, growth, share, segmentation, and geographic distribution have been included in the report to give a comprehensive view of the global protein therapeutics market. The report also covers current industrial developments and competitive landscape to help clients understand the current structure of the market and its progress in the coming years.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM557.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com/promotion.htm
About RNCOS:
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals study and analyze the industry and its various components, with comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the consultants in meeting their objectives in a cost-effective and timely manner.
|
|
NovoSeven clotting protein molecule Photo Mugs NovoSeven clotting protein, molecular model. NovoSeven is the brand name for an artificial version of the natural blood protein Factor VII, or proconvertin. This is an enzyme involved in the coagulation cascade, the physiological process that leads to blood clotting in the case of an injury. NovoSeven is produced by genetically modified bacteria, which have had the gene coding for the Factor VII p… |
|
|
Thrombin protein, secondary structure Photo Mugs Thrombin protein, computer model. Thrombin is a protein involved in the blood coagulation (clotting) process. It converts fibrinogen (a soluble plasma glycoprotein synthesised in the liver) to fibrin, a protein that is polymerised to form a mesh, or clot, (in conjunction with platelets) over a wound site. In this model the molecules shape (secondary structure) is seen, comprising alpha helices (co… |
|
|
Warfarin anticoagulant drug molecule Photo Mugs Warfarin anticoagulant drug molecule. Molecular model of warfarin, an anticoagulant used to treat blood clotting disorders. Warfarins name derives from the Wisconsin Alumni Research Foundation, where it was produced. It was introduced as a rat poison in 1948 and it was not until 1954 that it was recognised as a potential therapeutic anticoagulant in humans. It is now rarely used as rat poison, sin… |
|
|
Impaired Mobility: Physical Consequences (Immobility, Preventing Complications) (Volume One) Describes alterations in body functions occurring with impaired mobility. Common problems such as muscular atrophy, fluid and electrolyte disturbances, disorders in blood clotting mechanisms, disuse osteoporosis, retained respiratory secretions, and urinary stasis are discussed along with their long-term negative impact on patient health…. |
|
|
Understanding Hemophilia (Home Use) $24.95 Part of the award winning public television series Healthy Body/Healthy Mind. Bleeding due to a cut or wound can be a little scary at times, especially if your child is a hemophiliac. Hemophiliacs lack specific blood proteins known as clotting factors that our bodies need to control bleeding following an injury. Fortunately, there is far more hope than ever before for these young patients. This ep… |
|
|
Von Willebrand Disease (Home Use) $19.50 Part of the award winning public television series Healthy Body/Healthy Mind. Most people wouldn’t give a second thought to a minor cut. But for individuals with von Willebrand disease, bleeding is often a cause for concern, particularly when it involves a serious injury or surgery. Von Willebrand disease is a hereditary condition, making it the most common bleeding disorder. It afflicts men and w… |
|
|
Deadly Blood Clots: The Dangers of Venous Thromboembolism (Home Use) $24.95 Part of the award winning public television series Healthy Body/Healthy Mind. The dangers of blood clots are well known: they can cause heart attacks, strokes and other potentially fatal conditions. But there’s another medical hazard that occurs when the blood clot lives quietly deep in the veins of the legs. And when a part of this blood clot breaks off and travels to the lung the result can be … |
|
|
Quikclot Sport Brand Advanced Clotting Sponge ,Stop Bleeding Fast, 50 Gram Package $12.75 QuikClot sport is a battlefield proven way to stop serious bleeding. An Advanced Clotting Sponge for stopping traumaticbleeding. FDA approved version is ready for every medicalkit. Silver is antibacterial and recommended if it will takeover 24 hours to get professional help…. |
|
|
Israeli Bandage Battle Dressing, First Aid Compression Bandage Performance Systems presents an innovative, combat proven first-aid device for the staunching of blood flow from traumatic hemorrhage wounds in pre-hospital emergency situations. This 4″ wide, all-in-one device consolidates multiple first-aid devices such as a primary dressing, pressure applicator, secondary dressing, and a foolproof closure apparatus to secure the bandage in place. This internati… |
|
|
Adventure Medical Quikclot Sport Pack A hatchet to the foot or a gunshot wound to the shin isn’t funny, unless there was juggling involved. Either way, the Adventure Medical Quikclot Sport Pack uses a chemically inert substance to stop the bleeding faster than just applying pressure can. Two sizes (depending on inventory) of chemically treated mesh sponges lets you safely and more effectively reduce blood loss while you get your victi… |